• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Tuesday, July 5, 2022
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home National

Bharat Biotech Starts Phase III Trials For COVAXIN

by The Outlooker Web Desk
November 17, 2020
in National
0
Bharat Biotech Starts Phase III Trials For COVAXIN
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

This is India’s first phase 3 efficacy study for a COVID-19 vaccine.

Hyderabad:

Bharat Biotech announced the commencement of Phase III trials of COVAXIN on Monday.

The Phase III trials will involve 26,000 volunteers across India and will be conducted in partnership with ICMR. It is the largest clinical trial conducted for a COVID-19 vaccine in India.

This is India’s first phase 3 efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted in India. The trial has been registered at www.ctri.nic.in (CTRI/2020/11/028976) and approved by the Drugs Controller General of India.

Trial volunteers will receive two intramuscular injections about 28 days apart. Participants will be randomly assigned to receive COVAXIN(tm) or placebo. The trial is double-blinded, such that the investigators, the participants, and the company will not be aware of who is assigned to which group.

Newsbeep

COVAXIN has been evaluated in about 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity data. Volunteers who wish to participate in this trial should be adults over 18 years of age.

COVAXIN(tm), India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). This indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech”s BSL-3 (Bio-Safety Level 3) bio containment facility. COVAXIN(tm) is a highly purified and inactivated vaccine, manufactured in a vero cell manufacturing platform with an excellent safety track record of more than 300 million doses supplied.

Suchitra Ella, joint managing director of Bharat Biotech said, “The development and clinical evaluation of COVAXIN(tm) marks a significant milestone for vaccinology in India. It is important for Indian companies to innovate and develop indigenous vaccines, especially during a pandemic. COVAXIN(tm) has garnered interest from several countries worldwide for supplies and introduction.” 

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Economic Indicators: Is it the right time to go for stock shopping?

Economic Indicators: Is it the right time to go for stock shopping?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Eknath Shinde says he used to meet Fadnavis when his group MLAs were asleep
Politics

Eknath Shinde says he used to meet Fadnavis when his group MLAs were asleep

July 5, 2022
HDFC, HDFC Bank share prices jump over 1% as RBI approves merger proposal; should you buy, sell, hold?
Business

HDFC, HDFC Bank share prices jump over 1% as RBI approves merger proposal; should you buy, sell, hold?

July 5, 2022
UP Man Sells Chicken On Paper With Photo Of Hindu God, Goddess; Arrested: Report
National

UP Man Sells Chicken On Paper With Photo Of Hindu God, Goddess; Arrested: Report

July 5, 2022
Dr Reddy’s Laboratories rating: Buy | Healthy financials should aid growth
Business

Dr Reddy’s Laboratories rating: Buy | Healthy financials should aid growth

July 4, 2022

Connect with us

No Result
View All Result

Archives

  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Eknath Shinde says he used to meet Fadnavis when his group MLAs were asleep
  • HDFC, HDFC Bank share prices jump over 1% as RBI approves merger proposal; should you buy, sell, hold?
  • UP Man Sells Chicken On Paper With Photo Of Hindu God, Goddess; Arrested: Report

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.